NL-OMON39075已完成3 期
An open-label extension of study AC-066A301 investigating the safety and tolerability of ACT-385781A in patients with pulmonary arterial hypertension (PAH) - EPITOME-2 Extension
Actelion Pharmaceuticals0 个研究点目标入组 5 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 5
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •1. Signed informed consent prior to initiation of any study mandated procedure;2. Patients who completed participation in study AC 066A301;3. Patients who have not obtained access (i.e. reimbursement) to commercial EFI at the time of ending participation in study AC-066A301
排除标准
- •1. Patients who prematurely discontinued study drug in study AC-066A301;2. Patients for whom continued treatment with EFI is no longer considered appropriate
研究者
相似试验
进行中（未招募）
不适用
An extension of study AC-066A301 to investigate safety and tolerability of the study medication (epoprostenol for injection)Pulmonary Arterial HypertensionMedDRA version: 14.1Level: PTClassification code 10064911Term: Pulmonary arterial hypertensionSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersEUCTR2010-018320-10-NLACTELION Pharmaceuticals Ltd40
进行中（未招募）
不适用
An extension of study AC-066A301 to investigate safety and tolerability of the study medication (epoprostenol for injection)Hipertension Arterial PulmonarMedDRA version: 14.0Level: PTClassification code 10064911Term: Pulmonary arterial hypertensionSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersEUCTR2010-018320-10-ESACTELION Pharmaceuticals Ltd40
进行中（未招募）
不适用
An extension of study AC-066A301 to investigate safety and tolerability of the study medication (epoprostenol for injection)MedDRA version: 14.1Level: PTClassification code 10064911Term: Pulmonary arterial hypertensionSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersPulmonary Arterial HypertensionEUCTR2010-018320-10-BEACTELION Pharmaceuticals Ltd40
已完成
3 期
Epoprostenol for Injection in Patients With Pulmonary Arterial HypertensionPulmonary Arterial HypertensionNCT01470144Actelion41
已完成
4 期
Epoprostenol for Injection in Pulmonary Arterial Hypertension - Extension of AC-066A401Pulmonary Arterial HypertensionNCT01105117Actelion2